Maria T Arevalo

Title: Maria T Arevalo: Innovator in RNA Therapeutics and Vaccines

Introduction

Maria T Arevalo is a prominent inventor based in Athens, GA (US). She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference-based therapeutics and innovative vaccines. With a total of 3 patents to her name, Arevalo is recognized for her groundbreaking work in combating infectious diseases.

Latest Patents

Among her latest patents, one notable invention is an RNA interference-based therapeutic against anthrax. This invention includes siRNAs and antibodies that block the interaction between TEM8 and/or CMG2 cell surface proteins and anthrax toxin, along with methods for treating anthrax exposure. Another significant patent is for a dual-purpose universal influenza vaccine that confers protective immunity against anthrax. This invention comprises antigenic fusion proteins, nucleic acids encoding the fusion proteins, and methods of making and using the same, wherein the fusion protein is immunogenic across strains.

Career Highlights

Maria T Arevalo is affiliated with the Texas Tech University System, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of RNA therapeutics and vaccine development.

Collaborations

Arevalo has collaborated with notable colleagues, including Mingtao Zeng and Junwei Li, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Maria T Arevalo stands out as an innovative inventor in the field of biotechnology, with her patents reflecting her commitment to addressing critical health challenges. Her contributions to RNA therapeutics and vaccine development are paving the way for future advancements in medical science.